Take advantage of the "Nobel Prize" to let the development of traditional Chinese medicine industry go as far as possible.

On the evening of December 7, 2015, Tu Youyou, a lifelong researcher of the Nobel Prize-winning Chinese Academy of traditional Chinese Medicine, delivered a speech in Chinese entitled "Artemisinin-A Gift of traditional Chinese Medicine to the World" at the Nobel Hall of Karolinska Medical College in Sweden. On the 10th, she also attended the award ceremony. Tu Youyou's award not only attracted the attention of the major news media all over the world, but also made people realize once again the breadth and depth of Chinese medicine. However, for traditional Chinese medicine, the discovery of artemisinin is only "a small tender lotus just showing the tip of a tightly wrapped leaf." it is believed that traditional Chinese medicine will bring more and more gifts to the world.

Tu Youyou won the Nobel Prize, making traditional Chinese medicine, which has always been questioned as unscientific, finally exuberant and winning glory for the country, and made the world realize that traditional Chinese medicine is a great treasure house, and it is also considered by the industry to be the best time to carry forward Qihuang's skills. there is no doubt that it will inject "cardiotonic" into the positive development of traditional Chinese medicine and going to the world.

However, at present, Japan and South Korea account for 80% and 90% of the world traditional Chinese medicine market. As the birthplace of Chinese herbal medicine, China's share is only 2% of the global herbal medicine sales. Traditional Chinese medicine has been paid more and more attention in the world. However, China is only located in Japan and South Korea and other countries to provide raw materials. 75% of the raw materials for the production of Japanese traditional Chinese medicine preparations are imported from China.

According to statistics, Japan is currently the largest producer and consumer of traditional Chinese medicine except China. At present, there are more than 200 Chinese medicine factories in Japan, with an annual growth rate of 15 per cent and annual sales of 1.5 billion US dollars. About 148 kinds of traditional Chinese medicine have been approved by the Japanese government to apply the "national health insurance system." Experts said that Jinmiao Pharmaceutical, the largest Chinese medicine enterprise in Japan, is the biggest competitor to the internationalization of proprietary Chinese medicine in China. Jinmiao Pharmaceutical has successively established more than 70 GAP (quality Management Standards for the production and quality Management of traditional Chinese Medicinal Materials) planting bases in China. In the aspect of basic research, Jinmiao Pharmaceutical Industry has also invested a lot of manpower and material resources in pharmacology, toxicity, standardization of dosage form composition, standardization and so on. However, there is a gap in the source of traditional Chinese medicine bases in domestic traditional Chinese medicine enterprises. At present, Tongrentang has 8 GAP bases in China, which is the traditional Chinese medicine enterprise with the largest number of GAP bases in China, but it is still far from the number of bases in Jinmiao Pharmaceutical Industry.

In the long run, the traditional Chinese medicine industry is expected to usher in new growth.

In 2015, "some opinions of the State Council on supporting and promoting the Development of traditional Chinese Medicine" was issued as a new medical reform configuration document, and the traditional Chinese medicine industry rose to the national strategic level; this year, the State Council has issued the Development Plan of traditional Chinese Medicine Health Services (2015-2020) and the Protection and Development Plan of Chinese Medicinal Materials (2013-2020). Last month, the National Tourism Administration and the State Administration of traditional Chinese Medicine jointly issued the "guidance on promoting the healthy Tourism Development of traditional Chinese Medicine", which combines the hot tourism industry with traditional Chinese medicine and provides an effective path for the improvement of the traditional Chinese medicine industry chain and the "going out strategy". This month, the State Council adopted the "Chinese Medicine (draft)", which will be submitted to the standing Committee of the National people's Congress for deliberation. Once the draft is passed by legislation, China will have its first national law for the revitalization of traditional Chinese medicine.

The Ministry of Industry and Information Technology's "Plan for the Protection and Development of Chinese Medicinal Materials (2015-2020)" puts forward that "rely on the support of science and technology, scientifically develop the cultivation and breeding of Chinese medicinal materials, and strive to achieve the high quality and safety of Chinese medicinal materials, adequate supply and stable prices." the development goal of promoting the sustained and healthy development of the traditional Chinese medicine industry. Only by innovating the planting mode of traditional Chinese medicine can we continuously improve the quality of traditional Chinese medicine and lay the foundation for the whole Chinese medicine industry.

Based on the proposal of the plan, we can foresee the trend and development direction of the cultivation of traditional Chinese medicine in the future as follows:

First, planting on a large scale. The disadvantages of family planting are increasingly exposed, such as difficult to mechanize planting, difficult to manage scientifically, difficult to correct flowers in primary processing, difficult to rationalize storage, and the rural population is decreasing, planting groups are aging and labor costs are constantly rising. large-scale planting by cooperatives, large growers and companies contracted land is bound to be a trend, and large-scale planting can solve the problems of technology, management, storage and sales of household planting. Promote the traceability construction of the quality of traditional Chinese medicine and provide a stable and safe supply of goods.

Second, planting standardization. Rely on science and technology, strengthen basic research on the growth and development characteristics of traditional Chinese medicine, the relationship between efficacy and growth environment, select excellent varieties, research and development of green pest control technology, develop Chinese medicine precision operation, ecological cultivation, mechanized production and modern processing technology, build a standardized GAP planting base, and improve the modern production level of traditional Chinese medicine.

Third, planting is market-oriented. Traditional Chinese medicine production and circulation enterprises and traditional Chinese medicine production enterprises should unite with each other, implement the strategy of base co-construction and sharing, and jointly build a centralized continuous Chinese medicine production base in accordance with local conditions; at the same time, traditional Chinese medicine production enterprises should begin to develop industrial integrated production and operation, gradually supply the main body of the market of the provincial party committee, and realize the integration of supply, production and marketing.

Fourth, seed regionalization. Traditional Chinese medicine has specific requirements for the growth environment and has obvious regional characteristics. Each producing area should give priority to supporting characteristic varieties and giving consideration to effective varieties.

Now it seems that with the introduction of favorable policies and the creative ability of enterprises as the main body, it will promote the accelerated development of the industrialization process of the domestic traditional Chinese medicine industry, and the excellent essence of Chinese medical culture can be inherited.